These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16604029)

  • 1. [Acute encephalopathy after infusion of paclitaxel].
    Lachkar S; Bota S; Nouvet G; Thiberville L
    Rev Mal Respir; 2006 Feb; 23(1 Pt 1):73-7. PubMed ID: 16604029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute transient encephalopathy after paclitaxel infusion: report of three cases.
    Ziske CG; Schöttker B; Gorschlüter M; Mey U; Kleinschmidt R; Schlegel U; Sauerbruch T; Schmidt-Wolf IG
    Ann Oncol; 2002 Apr; 13(4):629-31. PubMed ID: 12056715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute transient encephalopathy after weekly paclitaxel infusion.
    Muallaoğlu S; Koçer M; Güler N
    Med Oncol; 2012 Jun; 29(2):1297-9. PubMed ID: 21618057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient encephalopathy after paclitaxel (Taxol) infusion.
    Perry JR; Warner E
    Neurology; 1996 Jun; 46(6):1596-9. PubMed ID: 8649555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.
    Doz F; Gentet JC; Pein F; Frappaz D; Chastagner P; Moretti S; Vassal G; Arditti J; Tellingen OV; Iliadis A; Catalin J
    Br J Cancer; 2001 Mar; 84(5):604-10. PubMed ID: 11237379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
    Rook J; Rosser T; Fangusaro J; Finlay J
    Pediatr Blood Cancer; 2008 Mar; 50(3):699-700. PubMed ID: 16991134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications.
    Kudlowitz D; Muggia F
    Expert Opin Drug Saf; 2014 Jun; 13(6):681-5. PubMed ID: 24749649
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
    Guglani S; Farrugia D; Elsdon M; Parmar M; Owen JR
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):160-1. PubMed ID: 12801056
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient encephalopathy after Taxol infusion.
    Walz R; Muxfeldt Bianchin M; Kliemann F
    Neurology; 1997 Oct; 49(4):1188-9. PubMed ID: 9339733
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer.
    O'Connor TL; Kossoff E
    Pharmacotherapy; 2009 Aug; 29(8):993-6. PubMed ID: 19637953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.
    Nieto Y; Cagnoni PJ; Bearman SI; Shpall EJ; Matthes S; DeBoom T; Barón A; Jones RB
    Clin Cancer Res; 1999 Mar; 5(3):501-6. PubMed ID: 10100699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
    Nishio S; Ota S; Sugiyama T; Matsuo G; Kawagoe H; Kumagai S; Ushijima K; Nishida T; Kamura T
    Int J Clin Oncol; 2003 Feb; 8(1):45-8. PubMed ID: 12601542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
    Tsavaris N; Polyzos A; Kosmas C; Giannikos L; Gogas J
    Cancer Chemother Pharmacol; 1997; 40(4):353-7. PubMed ID: 9225955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma.
    Bergmann TK; Filppula AM; Launiainen T; Nielsen F; Backman J; Brosen K
    Br J Clin Pharmacol; 2016 Feb; 81(2):313-5. PubMed ID: 26446447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
    Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.
    Gianni L; Munzone E; Capri G; Villani F; Spreafico C; Tarenzi E; Fulfaro F; Caraceni A; Martini C; Laffranchi A
    J Natl Cancer Inst; 1995 Aug; 87(15):1169-75. PubMed ID: 7674322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel.
    Lee RT; Oster MW; Balmaceda C; Hesdorffer CS; Vahdat LT; Papadopoulos KP
    Ann Oncol; 1999 Oct; 10(10):1245-7. PubMed ID: 10586344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
    Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W
    Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer.
    Au E; Tan EH; Ang PT
    Ann Oncol; 1998 Mar; 9(3):327-9. PubMed ID: 9602268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracing the incidence of paclitaxel-induced peripheral neuropathy.
    Argyriou AA
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):522-3. PubMed ID: 19674075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.